Last reviewed · How we verify
L-leucine
At a glance
| Generic name | L-leucine |
|---|---|
| Also known as | Leucine |
| Sponsor | Federal Scientific Clinical Centre of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogache |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Acute Effects of Onnit Alpha Brain on Cognition and Mood States (NA)
- Pivotal Study of N-acetyl-L-leucine for CACNA1A (PHASE3)
- Pre-Surgical Immunonutrition's Effect on Colorectal Surgery (NA)
- N-Acetyl-L-Leucine for Ataxia-Telangiectasia (A-T) (PHASE2)
- Leucine Requirements in School-Age Children (NA)
- How Animal and Plant Protein Shakes Change the Body's Nutrient and Health Responses (NA)
- Eucine-Restricted Diet in Gastric Cancer Patients (PHASE1)
- Protein Supplement and Exercise Training for the Treatment of Sarcopenia Risk in Older Adults (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: